en

PRODUCT DETAIL

Dailiport 5 mg

Code 3008D
MA number 59/0380/19-S
Product Form: cps pld 30x1x5 mg (blis.PVC/PVDC/Al-jednotliv.dáv.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AD Calcineurin inhibitors
L04AD02 Tacrolimus
Shelf life: 24
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 03.12.2019
Validity: 03.12.2024
MA renewed: Renewal application submitted
Pediatric warnings: Yes
SPC: SPC_Dailiport 0,5 mg_1 mg_3 mg_5 mg_07.2022.pdf  
PIL: PIL_Dailiport 0,5 mg_1 mg_3 mg_5 mg_07.2022.pdf  
Safety feature Yes
Data update: 11.11.2020
eu-flag.png sk-flag.png